Hepatitis B Patient Education
Patients with hepatitis B must be counseled on preventing transmission to contacts, protecting their liver health, and understanding when treatment and monitoring are necessary. 1
Preventing Transmission to Others
Contact Notification and Vaccination
- Notify all household members, sexual partners, and needle-sharing contacts that they need testing for HBV markers (HBsAg and anti-HBs) and vaccination if susceptible 1, 2
- Contacts should complete the full 3-dose hepatitis B vaccine series (at 0,1-2, and 4-6 months) 3
- Sexual partners must use condoms until they complete vaccination and demonstrate immunity (anti-HBs ≥10 mIU/mL) 1, 4
Blood and Body Fluid Precautions
- Cover all cuts and skin lesions to prevent spread of infectious secretions 1, 2
- Clean blood spills with bleach solution—HBV survives on surfaces for at least 1 week 2
- Never share items that could contact blood: toothbrushes, razors, or injection equipment 1
- Refrain from donating blood, plasma, tissue, or semen 1
Special Populations
Pregnant women with HBV: Newborns must receive both hepatitis B vaccine AND hepatitis B immune globulin (HBIG) within 12 hours of birth, achieving 95% efficacy in preventing perinatal transmission 2. Infants must complete the vaccine series and undergo follow-up testing at 9-12 months of age 2.
Women with viral loads >200,000 IU/mL should receive tenofovir (either tenofovir alafenamide 25 mg daily or tenofovir disoproxil fumarate 300 mg daily) starting at 28-32 weeks gestation 5.
Breastfeeding is safe as long as the infant receives proper immunoprophylaxis at birth 1, 5.
What Does NOT Spread Hepatitis B
Reassure patients that HBV is not transmitted through 1:
- Breastfeeding (with proper infant immunoprophylaxis)
- Kissing, hugging, or casual touching
- Coughing or sneezing
- Sharing eating utensils or drinking glasses
- Food or water
Patients should not be excluded from school, work, childcare, or other settings based solely on HBsAg status (unless prone to biting) 1.
Protecting Your Liver
Alcohol and Liver Health
Avoid or strictly limit alcohol consumption—heavy use (≥40 g/day) accelerates progression to cirrhosis and causes HCC to develop at younger ages in HBV carriers 2. Refer patients needing alcohol abuse evaluation immediately 1.
Hepatitis A Vaccination
All patients with chronic liver disease should receive hepatitis A vaccine (2 doses, 6-18 months apart) 1.
Specialist Care
Seek care from a provider experienced in hepatitis B management, as 15-25% of chronically infected persons face premature death from cirrhosis or liver cancer 1.
Medical and Dental Care Disclosure
Always inform healthcare and dental providers of HBsAg-positive status so they can evaluate and manage care appropriately 1.
For HBV-positive healthcare workers who are HBeAg-positive: do not perform invasive procedures without expert review panel guidance and patient notification 2.
Monitoring and Treatment Overview
Who Needs Treatment
Treatment should be initiated in patients with 6:
- Persistently elevated HBV DNA levels
- Elevated ALT (≥19 IU/L for women, ≥30 IU/mL for men)
- Advanced liver disease or significant fibrosis
First-line therapies include pegylated interferon-α, entecavir, or tenofovir 6.
Surveillance for Liver Cancer
Patients with chronic HBV face increased risk of hepatocellular carcinoma (HCC). Regular screening with alpha-fetoprotein (AFP) and ultrasound can detect small tumors (diameter <5 cm) in 57-83% of cases, enabling potentially curative treatment 2.
Common Pitfalls to Avoid
The CDC guidelines emphasize that patient education should be conducted in a culturally sensitive manner in the patient's primary language (both written and oral), ideally using bilingual, bicultural, medically trained interpreters 1. This is critical because less than one in five infected individuals globally is aware of their condition 7.
Contact vaccination success varies widely—only approximately 26% of identified contacts complete evaluation in national programs, though targeted programs achieve up to 85% 1. Healthcare providers must actively encourage patients to notify contacts rather than assuming it will happen automatically.
The burden of ensuring contact vaccination and managing transmission anxiety falls heavily on patients, particularly adolescents and young adults who face social and sexual exploration while dealing with fears of transmission 8. Expanding treatment access provides additional tools beyond behavioral interventions alone.